Along with the bone-derived osteocalcin, the osteocyte-derived sclerostin may regulate the Wnt/β-catenin signaling pathway, which is essential for regulating bone metabolism and cognitive function and has been associated with Alzheimer’s disease progression (14, 32, 33). This evidence concerns the gene BGLAP and early-onset autosomal dominant Alzheimer disease.